Prostaglandin (PG)E2 exhibits antifibrotic activity in vocal fold fibroblasts

Laryngoscope

Volumn 121, Issue 6, 2011, Pages 1261-1265

  Zhou, Hang ^a   Felsen, Diane ^b   Sandulache, Vlad C ^c   Amin, Milan R ^a   Kraus, Dennis H ^d   Branski, Ryan C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cyclooxygenase; Inflammation; Prostaglandin; Vocal fold

Indexed keywords

ANTIFIBROTIC AGENT; CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN;

ANTIFIBROTIC ACTIVITY; ARTICLE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; EX VIVO STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; VOCAL CORD; BIOSYNTHESIS; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; WOUND HEALING;

CELL CULTURE TECHNIQUES; CELL LINE; COLLAGEN; DINOPROSTONE; FIBROBLASTS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA1; VOCAL CORDS; WOUND HEALING;

EID: 79958293616     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.21795     Document Type: Article

References (33)

1. Ehrlich H. In: Garg H, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker; 2000:99-114.
2. Chin GS, Stelnicki EJ, Gittes GK, Longaker MT. In Garg H, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker; 2000:239-257.
3. Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing: VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 1990; 25:63-68.
4. Rowlatt U. Intrauterine wound healing in a 20 week human fetus. Virchows Arch A Pathol Anat Histol 1979;381:353-361. (Pubitemid 9212849)
5. Krummel TM, Nelson JM, Diegelmann RF, et al. Fetal response to injury in the rabbit. J Pediatr Surg 1987;22:640-644. (Pubitemid 17096972)
6. Morykwas MJ, Ledbetter MS, Ditesheim JA, White WL, Vander Ark AD, Argenta LC. Cellular inflammation of fetal excisional wounds: effects of amniotic fluid exclusion. Inflammation 1991;15:173-180.
7. Frantz FW, Bettinger DA, Haynes JH, et al. Biology of fetal repair: the presence of bacteria in fetal wounds induces an adult-like healing response. J Pediatr Surg 1993;28:428-433.
8. Kumta S, Ritz M, Hurley JV, Crowe D, Romeo R, O'Brien BM. Acute inflammation in foetal and adult sheep: the response to subcutaneous injection of turpentine and carrageenan. Br J Plast Surg 1994;47: 360-368. (Pubitemid 24223849)
9. Liechty KW, Crombleholme TM, Cass DL, Martin B, Adzick,N.S. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 1998;77:80-84. (Pubitemid 28364187)
10. Liechty KW, Kim HB, Adzick NS, Crombleholme TM. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 2000;35: 866-872.
11. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL- 6) production during scarless human fetal wound repair. Cytokine 2000; 12:671-676. (Pubitemid 30453496)
12. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-182.
13. Sandulache VC, Parekh A, Li-Korotsky HS, Dohar JE, Hebda PA. Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis Wound Rep Reg 2007;15:122-133.
14. Sandulache VC, Parekh A, Li-Korotsky HS, Dohar JE, Hebda PA. Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen 2006;14:633-643. (Pubitemid 44470082)
15. 2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics. Laryngoscope 2009;119:1365-1373.
16. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002;23:144-150. (Pubitemid 34178297)
17. Wilgus TA, Parrett ML, Ross MS, Tober KL, Robertson FM, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Adv Exp Med Biol 2002;507:85-92. (Pubitemid 37330166)
18. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002;110: 651-658. (Pubitemid 34988789)
19. Rossiello L, D'Andrea F, Grella R, et al. Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues. Wound Rep Reg 2009; 17:750-757.
20. Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Rep Reg 2003;11:25-34. (Pubitemid 36268606)
21. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004;24:40-46. (Pubitemid 38032806)
22. Ozaki T, Rennard SI, Crystal RG. Cyclooxygenase metabolites are compartmentalized in the human lower respiratory tract. J Appl Physiol 1987;62:219-222. (Pubitemid 17060619)
23. Welham NV, Lim X, Tateya I, Bless DM. Inflammatory factor profiles one hour following vocal fold injury. Ann Otol Rhinol Laryngol 2008;117: 145-152. (Pubitemid 351287918)
24. Branski R, Rosen C, Verdolini K, Hebda P. Biochemical markers associated with acute vocal fold wound healing: a rabbit model. J Voice 2005;19: 283-289. (Pubitemid 40724901)
25. Branski RC, Zhou H, Sandulache VC, Chen J, Felsen D, Kraus DH. Cyclooxygenase- 2 signaling in vocal fold fibroblasts. Laryngoscope 2010;120: 1826-1831.
26. Hirano S, Bless D, Heisey D, Ford C. Roles of hepatocyte growth factor and transforming growth factor B1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144-148. (Pubitemid 36050530)
27. Hirano S, Bless DM, Heisey D, Ford CN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2003;112:617-624. (Pubitemid 36858944)
28. Hirano S, Bless DM, Massey RJ, Hartig GK, Ford CN. Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor. Ann Otol Rhinol Laryngol 2003;112:1026-1033. (Pubitemid 37523615)
29. Branski RC, Barbieri SS, Weksler BB, et al. The effects of transforming growth factor-beta1 on human vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2009;118:218-226.
30. Branski RC, Rosen CA, Hebda PA, Verdolini K. Cytokine analysis of acute wound healing in the larynx: a rabbit model. J Voice 2005;19:283-289. (Pubitemid 40724901)
31. Keerthisingam CB, Jenkins RG, Harrison NK, et al. Cyclooxygenase-2 deficiency results in a loss of the anti-prolferative response to transforming growth factor-beta in human fibrotic lung fibrobasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001; 158:1411-1422. (Pubitemid 32281305)
32. Verrecchia F, Mauviel A. Transforming growth factor-beta and fibrosis. World J Gastroentrol 2007;13:3056-3052.
33. Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochem Biophys Acta 2008;1782:197-228